Boston, MA, April 28, 2021 – Amwell®, (NYSE: AMWL) a national
telehealth leader, today unveiled its next-generation Converge™ telehealth
platform at its annual Client Forum. Born out of the profound shift in
telehealth usage during the COVID 19 pandemic, from transactional to
longitudinal care, this flexible and scalable platform is designed to provide
deeper connectivity between healthcare players with unmatched simplicity,
reliability, and scalability. With the Converge platform, Amwell’s products,
programs, modules and Carepoint™ devices, as well as applications from leading
innovators, will be available in one place with a single code base, further
enhancing Amwell’s seamless and unified care experience and strengthening
existing patient provider relationships across all types of care.
“Digital distribution of care is here,” said Dr. Roy Schoenberg,
President and co-CEO, Amwell. “Telehealth morphed, almost overnight, from a
promising technology to an existential platform in the operation of healthcare
– alongside EHRs, claim systems and e-prescribing. We are witnessing a new
consensus that the future care of any one patient will inevitably involve a mix
of physical, digital and asynchronous/AI-based care. We designed the Converge
platform to support, simplify, and delight patients, clinicians, and the
healthcare tenants around them, as they rapidly embrace this new balance of
care. Its open architecture invites customers and innovators to extend their
reach, and all of us to imagine a more graceful healthcare experience, with
technology on our side.”
The platform’s open architecture is designed to host and operate
applications from innovators – further enabling rapid progress towards
digitally enabled healthcare. By embracing a diverse group of developers as
part of the platform, clients are able to pick and choose the capabilities that
matter most to them. Examples include:
·
Google Cloud: Leveraging AI and natural
language processing technologies powered by Google Cloud, real-time captioning
and translation services will advance provider choices for patient education by
surfacing related health education materials based on a patient’s visit.
AI-powered tools will engage patients and their care teams before, during and
after visits to drive better health insights and outcomes.
·
TytoCare: Livestream integration enables
improved diagnosis and treatment for virtual visits using the award-winning
TytoCare handheld exam kit featuring built-in visual guidance technology.
·
The Clinic: Providers can request virtual
second opinion services for patients, connecting them to one of 3,500 Cleveland
Clinic physicians in over 550 advanced sub-specialties via the Amwell platform.
·
Biobeat: Offering a wearable, wireless remote
patient monitoring device in two forms: a wrist-monitor for long-term use and a
disposable chest-monitor for short-term use, Biobeat provides a tool for the
continuous monitoring of 15 vital signs including: blood pressure, heart rate,
blood oxygenation and respiratory rate. Biobeat devices are used by healthcare
organizations and pharma companies globally; a Biobeat app would enable
providers to receive alerts on patient health status and potential
deterioration via an AI-powered, automated real-time early warning score system.
In addition, Amwell offered a peek at its forthcoming Home TV
solution. Developed in collaboration with Solaborate, the Home TV Carepoint device,
powered by advanced AI, is designed to bring hospital care into the home
environment via an easy-to-use TV-based experience.
“We realize that transformation is all about partnership and
collaboration,” said Dr. Ido Schoenberg, Chairman and co-CEO, Amwell. “By
bringing together Amwell’s best-in-class solutions with those from across the
ecosystem, we are uniquely able to deliver a solution that both supports a long
list of capabilities across the full care continuum, from episodic to
longitudinal care, and enables native connectivity between all players. We also
understand that these players have unique needs, and these needs will evolve,
so we have built the Converge platform to be highly scalable, modular and
future-ready, giving clients the ability to reimagine new ways of using
telehealth over time.”
“At the start of the pandemic, we integrated telehealth as a way
to meet demand but have quickly realized the need to make telehealth a
permanent component of our care access model,” said Susan Pleasants, MD, the
Chief Medical Informatics Officer with M Health Fairview. “Core to the success
of our program and high satisfaction rates thus far has been having a virtual
care platform that is fully integrated with our EHR and embedded in our patient
portal. These components have allowed us to create a more simple, more cohesive
user experience for both patients and providers, while helping us increase
efficiency and expand the reach of our virtual services to other community
locations.”
Central to the Converge platform is its enhanced reliability and
simplicity, featuring fast and reliable video and audio connections and the
ability to easily upgrade these core components over time – ensuring that
clients have access to the best connectivity experience for the future. The
platform can be integrated with existing workflows, EHRs, patient portals, and
consumer experiences, to support the delivery of care no matter where the
patient or provider originates and resulting in faster and easier deployment.
The single platform approach means a unified identity system that enables a
streamlined and regulatory compliant exchange of information and services
across the ecosystem.
“UPMC Health Plan expanded its telehealth capacity during the
pandemic to meet increasing member demand, which quintupled in the 12 months
after the start of the pandemic,” said Natasha Khouri, Associate Vice
President, Telehealth Strategy Solutions, UPMC Health Plan. “The past year has
proven that telemedicine can be a convenient, clinically appropriate means by
which to deliver accessible, high-quality health care to our members and we
expect to continue to add even more virtual care options to further strengthen
member-provider relationships and improve health outcomes.”
To learn more about the Converge platform visit: https://business.amwell.com/solution-overview/
About Amwell
Amwell is a leading telehealth platform in the United States and
globally, connecting and enabling providers, insurers, patients, and innovators
to deliver greater access to more affordable, higher quality care. Amwell
believes that digital care delivery will transform healthcare. The Company
offers a single, comprehensive platform to support all telehealth needs from
urgent to acute and post-acute care, as well as chronic care management and
healthy living. With over a decade of experience, Amwell powers telehealth
solutions for over 2,000 hospitals and over 55 health plan partners with over
36,000 employers, covering over 80 million lives. For more information, please
visit https://business.amwell.com/.
American Well, Amwell, Converge and Carepoint are registered
trademarks or trademarks of American Well Corporation in the United States and
other countries. All other trademarks used herein are the property of their
respective owners.
Forward-Looking Statements
This press release contains forward-looking statements about us
and our industry that involve substantial risks and uncertainties and are based
on our beliefs and assumptions and on information currently available to us.
All statements other than statements of historical facts contained in this
press release, including statements regarding our future results of operations,
financial condition, business strategy and plans and objectives of management
for future operations, are forward-looking statements. In some cases, you can
identify forward-looking statements because they contain words such as
“anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,”
“plan,” “potential,” “predict,” “project,” “should,” “will,” or “would,” or the
negative of these words or other similar terms or expressions.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause our actual results, performance,
or achievements to be materially different from any future results, performance
or achievements expressed or implied by the forward-looking statements.
Forward-looking statements represent our beliefs and assumptions only as of the
date of this release. These statements, and related risks, uncertainties,
factors and assumptions, include, but are not limited to: weak growth and
increased volatility in the telehealth market; inability to adapt to rapid
technological changes; increased competition from existing and potential new
participants in the healthcare industry; changes in healthcare laws,
regulations or trends and our ability to operate in the heavily regulated
healthcare industry; our ability to comply with federal and state privacy
regulations; the significant liability that could result from a cybersecurity
breach; and other factors described under ‘Risk Factors’ in our Annual Report
on Form 10-K for the year ended December 31, 2020 and our subsequent filings
with the SEC. These risks are not exhaustive. Except as required by law, we
assume no obligation to update these forward-looking statements, or to update
the reasons actual results could differ materially from those anticipated in
the forward-looking statements, even if new information becomes available in
the future. Further information on factors that could cause actual results to
differ materially from the results anticipated by our forward-looking
statements is included in the reports we have filed or will file with the
Securities and Exchange Commission. These filings, when available, are
available on the investor relations section of our website at
investors.amwell.com and on the SEC’s website at www.sec.gov.
No comments:
Post a Comment